van der Rhee H J, van Gelderen H H, Polano M K
Acta Derm Venereol. 1980;60(3):274-5.
In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.
在5名年龄在8至12岁之间的儿童中，使用Ro 10-9359治疗银屑病或变异性红角皮病11至17个月，未导致明显的生长发育迟缓，且取得了极佳的治疗效果。
